Investigation	O
of	O
Health	O
Effects	O
According	O
to	O
the	O
Exposure	O
of	O
Low	O
Concentration	O
Arsenic	O
Contaminated	O
Ground	O
Water	O

Recent	O
epidemiological	O
studies	O
have	O
reported	O
adverse	O
health	O
effects	O
,	O
including	O
skin	B-DS
cancer	I-DS
,	O
due	O
to	O
low	O
concentrations	O
of	O
arsenic	O
via	O
drinking	O
water	O
.	O

We	O
conducted	O
a	O
study	O
to	O
assess	O
whether	O
low	O
arsenic	O
contaminated	O
ground	O
water	O
affected	O
health	O
of	O
the	O
residents	O
who	O
consumed	O
it	O
.	O

For	O
precise	O
biomonitoring	O
results	O
,	O
the	O
inorganic	O
(	O
trivalent	O
arsenite	O
(	O
As	O
III	O
)	O
and	O
pentavalent	O
arsenate	O
(	O
As	O
V	O
))	O
and	O
organic	O
forms	O
(	O
monomethylarsonate	O
(	O
MMA	O
)	O
and	O
dimethylarsinate	O
(	O
DMA	O
))	O
of	O
arsenic	O
were	O
separately	O
quantified	O
by	O
combining	O
high	O
-	O
performance	O
liquid	O
chromatography	O
and	O
inductively	O
coupled	O
plasma	O
mass	O
spectroscopy	O
from	O
urine	O
samples	O
.	O

In	O
conclusion	O
,	O
urinary	O
As	O
III	O
,	O
As	O
V	O
,	O
MMA	O
,	O
and	O
hair	O
arsenic	O
concentrations	O
were	O
significantly	O
higher	O
in	O
residents	O
who	O
consumed	O
arsenic	O
contaminated	O
ground	O
water	O
than	O
control	O
participants	O
who	O
consumed	O
tap	O
water	O
.	O

But	O
,	O
most	O
health	O
screening	O
results	O
did	O
not	O
show	O
a	O
statistically	O
significant	O
difference	O
between	O
exposed	O
and	O
control	O
subjects	O
.	O

We	O
presume	O
that	O
the	O
elevated	O
arsenic	O
concentrations	O
may	O
not	O
be	O
sufficient	O
to	O
cause	O
detectable	O
health	O
effects	O
.	O

Consumption	O
of	O
arsenic	O
contaminated	O
ground	O
water	O
could	O
result	O
in	O
elevated	O
urinary	O
organic	O
and	O
inorganic	O
arsenic	O
concentrations	O
.	O

We	O
recommend	O
immediate	O
discontinuation	O
of	O
ground	O
water	O
supply	O
in	O
this	O
area	O
for	O
the	O
safety	O
of	O
the	O
residents	O
.	O

1	O
.	O

Introduction	O

Arsenic	O
is	O
present	O
in	O
the	O
form	O
of	O
inorganic	O
arsenic	O
and	O
organic	O
arsenic	O
in	O
ecological	O
environments	O
.	O

The	O
toxicity	O
of	O
arsenic	O
is	O
different	O
according	O
to	O
the	O
type	O
,	O
and	O
inorganic	O
arsenic	O
is	O
more	O
toxic	O
than	O
organic	O
arsenic	O
,	O
of	O
these	O
,	O
trivalent	O
arsenite	O
is	O
more	O
toxic	O
than	O
pentavalent	O
arsenate	O
[	O
1	O
].	O

Inorganic	O
arsenic	O
is	O
mainly	O
derived	O
from	O
the	O
environment	O
,	O
and	O
organic	O
arsenic	O
is	O
mainly	O
consumed	O
as	O
food	O
.	O

Therefore	O
,	O
in	O
the	O
risk	O
assessment	O
,	O
it	O
is	O
necessary	O
to	O
distinguish	O
between	O
inorganic	O
arsenic	O
and	O
organic	O
arsenic	O
.	O

Arsenic	O
exposure	O
via	O
drinking	O
water	O
is	O
a	O
very	O
important	O
public	O
health	O
concern	O
worldwide	O
.	O

The	O
severity	O
of	O
the	O
health	O
effects	O
of	O
arsenic	O
in	O
drinking	O
water	O
is	O
constantly	O
being	O
reevaluated	O
by	O
various	O
government	O
agencies	O
.	O

Hyperkeratosis	B-DS
,	O
hyperpigmentation	O
,	O
and	O
hypopigmentation	B-DS
[	O
2	O
]	O
are	O
representative	O
skin	O
symptoms	O
that	O
are	O
the	O
first	O
to	O
be	O
manifested	O
by	O
chronic	O
arsenic	O
exposure	O
and	O
are	O
also	O
used	O
as	O
clinical	O
indicators	O
of	O
arsenic	O
exposure	O
.	O

In	O
addition	O
,	O
exposure	O
to	O
arsenic	O
in	O
drinking	O
water	O
has	O
been	O
associated	O
with	O
respiratory	O
,	O
neurological	O
,	O
and	O
diabetic	B-DS
mellitus	I-DS
.	O

It	O
has	O
been	O
reported	O
that	O
chronic	O
respiratory	O
inflammation	O
are	O
caused	O
by	O
arsenic	O
-	O
induced	O
respiratory	B-DS
diseases	I-DS
[	O
3	O
],	O
and	O
peripheral	B-DS
neuropathy	I-DS
,	O
encephalopathy	B-DS
,	O
and	O
polyneuropathy	B-DS
are	O
caused	O
by	O
nervous	B-DS
system	I-DS
diseases	I-DS
[	O
4	O
].	O

An	O
epidemiologic	O
report	O
on	O
the	O
risk	O
of	O
miscarriage	B-DS
and	O
preterm	O
birth	O
in	O
chronic	O
exposure	O
to	O
arsenic	O
during	O
pregnancy	O
[	O
5	O
],	O
and	O
the	O
report	O
of	O
congenital	O
anomalies	O
[	O
6	O
]	O
suggest	O
that	O
exposure	O
to	O
arsenic	O
may	O
cause	O
reproductive	O
and	O
developmental	O
abnormalities	O
[	O
7	O
].	O

Furthermore	O
,	O
various	O
harmful	O
health	O
effects	O
due	O
to	O
exposure	O
to	O
low	O
concentrations	O
of	O
inorganic	O
arsenic	O
have	O
been	O
reported	O
in	O
many	O
studies	O
[	O
8	O
,	O
9	O
,	O
10	O
,	O
11	O
].	O

In	O
a	O
recent	O
epidemiological	O
study	O
,	O
various	O
health	O
effects	O
,	O
including	O
skin	B-DS
cancer	I-DS
,	O
have	O
been	O
reported	O
to	O
be	O
caused	O
by	O
exposure	O
to	O
low	O
concentrations	O
of	O
arsenic	O
(	O
10	O
µg	O
/	O
L	O
)	O
via	O
drinking	O
water	O
[	O
12	O
].	O

Some	O
studies	O
have	O
also	O
shown	O
that	O
well	O
water	O
samples	O
containing	O
arsenic	O
concentrations	O
of	O
>	O
1	O
.	O
0	O
µg	O
/	O
L	O
were	O
associated	O
with	O
skin	B-DS
cancer	I-DS
[	O
13	O
].	O

Therefore	O
,	O
the	O
United	O
States	O
Environmental	O
Protection	O
Agency	O
,	O
World	O
Health	O
Organization	O
,	O
and	O
the	O
Food	O
and	O
Drug	O
Administration	O
have	O
all	O
lowed	O
the	O
international	O
cut	O
off	O
for	O
total	O
arsenic	O
concentration	O
in	O
drinking	O
water	O
from	O
50	O
µg	O
/	O
L	O
to	O
10	O
µg	O
/	O
L	O
[	O
14	O
,	O
15	O
].	O

In	O
accordance	O
with	O
this	O
global	O
trend	O
,	O
Korea	O
has	O
also	O
decreased	O
the	O
cut	O
off	O
from	O
50	O
µg	O
/	O
L	O
to	O
10	O
µg	O
/	O
L	O
in	O
the	O
2007	O
[	O
16	O
].	O

All	O
local	O
governments	O
under	O
the	O
Korean	O
system	O
are	O
required	O
to	O
conduct	O
water	O
quality	O
tests	O
annually	O
according	O
to	O
the	O
law	O
.	O

As	O
a	O
result	O
of	O
the	O
water	O
quality	O
test	O
,	O
some	O
area	O
residents	O
,	O
including	O
children	O
,	O
were	O
found	O
to	O
have	O
taken	O
arsenic	O
contaminated	O
drinking	O
water	O
that	O
exceeds	O
the	O
maximum	O
allowable	O
criteria	O
(	O
10	O
µg	O
/	O
L	O
).	O

Moreover	O
,	O
owing	O
to	O
poor	O
knowledge	O
of	O
the	O
toxicity	O
of	O
the	O
arsenic	O
,	O
communities	O
have	O
excessive	O
anxiety	B-DS
of	O
arsenic	O
toxicity	O
health	O
risks	O
.	O

It	O
has	O
been	O
raised	O
the	O
need	O
of	O
a	O
health	O
impact	O
assessment	O
and	O
an	O
epidemiological	O
study	O
by	O
local	O
residents	O
and	O
non	O
-	O
governmental	O
organization	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
and	O
evaluate	O
arsenic	O
species	O
concentration	O
and	O
the	O
health	O
effects	O
that	O
are	O
associated	O
with	O
short	O
-	O
term	O
(	O
within	O
one	O
year	O
)	O
arsenic	O
exposure	O
via	O
contaminated	O
drinking	O
water	O
.	O

The	O
secondary	O
aim	O
was	O
to	O
establish	O
prevention	O
strategies	O
for	O
arsenic	O
related	O
diseases	O
by	O
determining	O
the	O
route	O
of	O
arsenic	O
exposure	O
,	O
and	O
to	O
disseminate	O
relevant	O
scientific	O
information	O
within	O
communities	O
that	O
have	O
expressed	O
anxiety	B-DS
towards	O
the	O
health	O
effects	O
of	O
arsenic	O
exposure	O
.	O

2	O
.	O

Materials	O
and	O
Methods	O

2	O
.	O
1	O
.	O

Participants	O

The	O
overall	O
survey	O
follow	O
according	O
the	O
passage	O
of	O
time	O
is	O
shown	O
in	O
Figure	O
1	O
.	O

Among	O
the	O
water	O
quality	O
tests	O
that	O
were	O
conducted	O
on	O
small	O
-	O
scale	O
water	O
supply	O
systems	O
in	O
Korea	O
(	O
temporary	O
water	O
supply	O
,	O
ground	O
water	O
),	O
we	O
used	O
data	O
for	O
five	O
facilities	O
with	O
arsenic	O
concentrations	O
exceeding	O
the	O
allowable	O
threshold	O
in	O
our	O
analysis	O
.	O

These	O
five	O
water	O
treatment	O
facilities	O
supplied	O
water	O
to	O
five	O
villages	O
and	O
one	O
elementary	O
school	O
.	O

The	O
residents	O
and	O
elementary	O
school	O
students	O
who	O
used	O
the	O
water	O
from	O
these	O
facilities	O
were	O
enrolled	O
(	O
n	O
=	O
144	O
).	O

Residents	O
of	O
areas	O
with	O
similar	O
(	O
i	O
)	O
living	O
conditions	O
,	O
(	O
ii	O
)	O
age	O
distribution	O
,	O
and	O
(	O
iii	O
)	O
population	O
size	O
as	O
the	O
exposure	O
areas	O
,	O
wherein	O
(	O
iv	O
)	O
cooperation	O
with	O
residents	O
would	O
be	O
smooth	O
,	O
and	O
(	O
v	O
)	O
water	O
was	O
supplied	O
from	O
a	O
public	O
water	O
supply	O
system	O
and	O
not	O
from	O
a	O
temporary	O
system	O
were	O
selected	O
as	O
control	O
participants	O
(	O
n	O
=	O
65	O
).	O

To	O
minimize	O
selection	O
bias	O
,	O
we	O
conducted	O
a	O
complete	O
enumeration	O
survey	O
.	O

Prior	O
to	O
the	O
study	O
,	O
all	O
households	O
were	O
visited	O
,	O
and	O
the	O
residents	O
were	O
informed	O
about	O
arsenic	O
exposure	O
in	O
drinking	O
water	O
.	O

Those	O
residents	O
who	O
agreed	O
to	O
participate	O
in	O
the	O
study	O
were	O
included	O
in	O
the	O
health	O
impact	O
assessment	O
surveys	O
.	O

This	O
study	O
had	O
a	O
community	O
-	O
based	O
intervention	O
design	O
.	O

2	O
.	O
2	O
.	O

Sample	O
Collection	O

According	O
to	O
the	O
registration	O
data	O
,	O
the	O
population	O
of	O
the	O
five	O
target	O
villages	O
comprised	O
132	O
households	O
and	O
247	O
residents	O
.	O

Thus	O
,	O
a	O
total	O
of	O
99	O
adults	O
,	O
including	O
83	O
residents	O
(	O
33	O
.	O
6	O
%)	O
and	O
16	O
individuals	O
staying	O
in	O
the	O
villages	O
for	O
their	O
business	O
,	O
participated	O
in	O
the	O
health	O
impact	O
survey	O
.	O

Additionally	O
,	O
45	O
children	O
aged	O
below	O
12	O
years	O
attending	O
the	O
elementary	O
schools	O
in	O
the	O
exposure	O
areas	O
were	O
surveyed	O
in	O
the	O
same	O
manner	O
as	O
the	O
adult	O
participants	O
.	O

The	O
health	O
impact	O
assessment	O
included	O
a	O
survey	O
questionnaire	O
and	O
collection	O
of	O
blood	O
,	O
urine	O
,	O
and	O
hair	O
specimens	O
.	O

Blood	O
specimens	O
were	O
collected	O
into	O
BD	O
Vacutainer	O
tubes	O
,	O
in	O
which	O
an	O
anticoagulant	O
was	O
added	O
;	O
the	O
tubes	O
were	O
placed	O
on	O
a	O
roll	O
mixer	O
to	O
prevent	O
coagulation	O
and	O
then	O
stored	O
in	O
a	O
deep	O
freezer	O
at	O
–	O
80	O
°	O
C	O
until	O
analysis	O
.	O

After	O
the	O
participants	O
were	O
instructed	O
regarding	O
the	O
urine	O
collection	O
method	O
to	O
prevent	O
contamination	O
,	O
spot	O
urine	O
specimens	O
were	O
collected	O
,	O
divided	O
into	O
several	O
tubes	O
,	O
and	O
stored	O
in	O
a	O
deep	O
freezer	O
at	O
–	O
80	O
°	O
C	O
until	O
analysis	O
.	O

Hair	O
specimens	O
were	O
stored	O
after	O
being	O
secured	O
in	O
hair	O
specimen	O
envelopes	O
.	O

The	O
environmental	O
impact	O
assessment	O
comprised	O
water	O
,	O
soil	O
,	O
and	O
crop	O
analyses	O
.	O

In	O
the	O
target	O
villages	O
,	O
water	O
that	O
was	O
pumped	O
out	O
from	O
the	O
groundwater	O
well	O
was	O
disinfected	O
in	O
a	O
storage	O
tank	O
and	O
distributed	O
to	O
each	O
house	O
.	O

Drinking	O
water	O
samples	O
were	O
collected	O
from	O
the	O
source	O
well	O
of	O
each	O
village	O
.	O

In	O
general	O
,	O
two	O
samples	O
(	O
before	O
and	O
after	O
application	O
of	O
an	O
arsenic	O
filter	O
)	O
were	O
collected	O
from	O
each	O
groundwater	O
well	O
.	O

The	O
water	O
sample	O
was	O
collected	O
in	O
a	O
prewashed	O
plastic	O
sampling	O
bottle	O
after	O
pumping	O
approximately	O
40	O
L	O
of	O
water	O
into	O
the	O
pipeline	O
.	O

The	O
water	O
samples	O
were	O
stored	O
in	O
an	O
ice	O
box	O
until	O
laboratory	O
analysis	O
.	O

Surface	O
soil	O
(	O
0	O
−	O
10	O
cm	O
depth	O
)	O
was	O
collected	O
from	O
farmland	O
in	O
the	O
studied	O
area	O
with	O
a	O
prewashed	O
hand	O
auger	O
and	O
transferred	O
to	O
plastic	O
bags	O
.	O

The	O
soil	O
samples	O
were	O
air	O
-	O
dried	O
for	O
five	O
days	O
and	O
sieved	O
with	O
a	O
100	O
-	O
mesh	O
sieve	O
for	O
acid	O
digestion	O
.	O

Samples	O
of	O
crops	O
such	O
as	O
rice	O
,	O
red	O
pepper	O
,	O
and	O
beans	O
were	O
collected	O
from	O
the	O
same	O
farmland	O
area	O
around	O
the	O
groundwater	O
wells	O
as	O
the	O
soil	O
sample	O
,	O
and	O
were	O
washed	O
with	O
distilled	O
water	O
.	O

2	O
.	O
3	O
.	O

Metal	O
Analysis	O

Urine	O
specimens	O
were	O
filtered	O
using	O
a	O
0	O
.	O
22	O
µm	O
filter	O
to	O
remove	O
impurities	O
and	O
appropriately	O
diluted	O
in	O
distilled	O
water	O
.	O

Speciation	O
was	O
carried	O
out	O
by	O
using	O
a	O
phosphate	O
buffer	O
via	O
a	O
high	O
-	O
performance	O
liquid	O
chromatography	O
(	O
HPLC	O
)	O
system	O
(	O
Agilent	O
Technologies	O
1260	O
,	O
Santa	O
Clara	O
,	O
CA	O
,	O
USA	O
),	O
on	O
which	O
a	O
Hamilton	O
PRP	O
X	O
-	O
100	O
column	O
was	O
mounted	O
.	O

The	O
inorganic	O
form	O
(	O
trivalent	O
arsenite	O
(	O
As	O
III	O
)	O
and	O
pentavalent	O
arsenate	O
(	O
As	O
V	O
)	O
and	O
organic	O
forms	O
(	O
monomethylarsonate	O
(	O
MMA	O
)	O
and	O
dimethylarsinate	O
(	O
DMA	O
))	O
of	O
arsenic	O
were	O
separately	O
quantified	O
by	O
combining	O
HPLC	O
and	O
inductively	O
coupled	O
plasma	O
-	O
mass	O
spectroscopy	O
(	O
ICP	O
-	O
MS	O
)	O
(	O
Agilent	O
Technologies	O
7700	O
series	O
,	O
Santa	O
Clara	O
,	O
CA	O
,	O
USA	O
).	O

Calibration	O
curves	O
were	O
constructed	O
based	O
on	O
the	O
standards	O
including	O
As	O
III	O
,	O
As	O
V	O
,	O
DMA	O
,	O
and	O
MMA	O
,	O
and	O
the	O
accuracy	O
of	O
the	O
analysis	O
was	O
confirmed	O
using	O
two	O
types	O
of	O
standard	O
reference	O
material	O
(	O
SRM	O
,	O
NIST	O
SRM	O
2669	O
&	O
NIES	O
No	O
.	O
18	O
).	O

Arsenic	O
and	O
metals	O
(	O
Cd	O
,	O
Cu	O
,	O
Hg	O
,	O
Pb	O
,	O
Cr	O
,	O
Zn	O
,	O
Ni	O
)	O
in	O
water	O
,	O
soil	O
,	O
and	O
rice	O
were	O
analyzed	O
for	O
environmental	O
exposure	O
assessment	O
.	O

The	O
water	O
samples	O
were	O
acidified	O
with	O
a	O
few	O
drops	O
of	O
nitric	O
acid	O
and	O
analyzed	O
via	O
ICP	O
-	O
MS	O
,	O
which	O
refers	O
to	O
American	O
Public	O
Health	O
Association	O
,	O
the	O
American	O
Water	O
Works	O
Association	O
,	O
and	O
the	O
Water	O
Environment	O
Federation	O
standard	O
method	O
(	O
Part	O
3125	O
)	O
[	O
17	O
],	O
and	O
Environmental	O
Protection	O
Agency	O
method	O
(	O
EPA	O
)	O
method	O
(	O
Method	O
200	O
.	O
8	O
)	O
[	O
18	O
].	O

An	O
EPA	O
method	O
(	O
Method	O
3051	O
)	O
[	O
19	O
]	O
was	O
used	O
for	O
the	O
extraction	O
of	O
metals	O
from	O
the	O
soil	O
samples	O
.	O

The	O
air	O
-	O
dried	O
soil	O
samples	O
(	O
0	O
.	O
5	O
g	O
)	O
were	O
placed	O
in	O
a	O
pre	O
-	O
acid	O
washed	O
Teflon	O
tube	O
and	O
9	O
.	O
5	O
mL	O
of	O
nitric	O
acid	O
was	O
added	O
.	O

The	O
Teflon	O
tube	O
was	O
installed	O
in	O
a	O
microwave	O
system	O
wherein	O
the	O
extraction	O
took	O
place	O
for	O
15	O
min	O
.	O

The	O
extracted	O
solution	O
was	O
diluted	O
with	O
1	O
.	O
0	O
%	O
nitric	O
acid	O
and	O
analyzed	O
with	O
ICP	O
atomic	O
emission	O
spectroscopy	O
(	O
Agilent	O
Technologies	O
720	O
series	O
,	O
Santa	O
Clara	O
,	O
CA	O
,	O
USA	O
).	O

Rice	O
samples	O
were	O
polished	O
and	O
the	O
edible	O
portions	O
of	O
the	O
other	O
crops	O
were	O
freeze	O
-	O
dried	O
.	O

The	O
dried	O
samples	O
were	O
ground	O
with	O
a	O
mortar	O
,	O
and	O
approximately	O
0	O
.	O
5	O
g	O
of	O
the	O
ground	O
crop	O
sample	O
was	O
digested	O
using	O
9	O
.	O
5	O
mL	O
of	O
nitric	O
acid	O
in	O
a	O
microwave	O
digestion	O
equipment	O
.	O

The	O
prepared	O
sample	O
solution	O
was	O
diluted	O
with	O
water	O
and	O
analyzed	O
with	O
ICP	O
-	O
MS	O
.	O

2	O
.	O
4	O
.	O

Health	O
Examination	O

We	O
conducted	O
a	O
health	O
examination	O
to	O
evaluate	O
the	O
health	O
effects	O
of	O
the	O
arsenic	O
exposure	O
.	O

The	O
health	O
examination	O
test	O
included	O
complete	O
blood	O
cell	O
count	O
,	O
liver	O
function	O
test	O
,	O
renal	O
function	O
test	O
,	O
chest	O
radiography	O
,	O
and	O
electrocardiogram	O
as	O
a	O
diagnostic	O
test	O
.	O

Tumor	B-DS
markers	O
,	O
such	O
as	O
alpha	B-GP
fetoprotein	I-GP
,	O
carcinoembryonic	B-GP
antigen	I-GP
,	O
carbohydrate	O
antigen	O
19	O
-	O
9	O
,	O
cancer	B-GP
antigen	I-GP
125	I-GP
,	O
prostate	B-GP
specific	I-GP
antigen	I-GP
,	O
and	O
cytokeratin	B-GP
-	I-GP
19	I-GP
fragments	O
were	O
used	O
as	O
tumor	B-DS
markers	O
for	O
liver	O
,	O
colon	O
,	O
pancreas	O
,	O
ovary	O
,	O
prostate	O
,	O
and	O
lung	O
respectively	O
.	O

2	O
.	O
5	O
.	O

Statistical	O
Analysis	O

After	O
speciation	O
,	O
the	O
distribution	O
of	O
arsenic	O
concentrations	O
in	O
urine	O
and	O
hair	O
were	O
found	O
to	O
be	O
skewed	O
(	O
skewness	O
>	O
0	O
).	O

Hence	O
,	O
the	O
geometric	O
mean	O
(	O
GM	O
)	O
and	O
95	O
%	O
confidence	O
interval	O
(	O
95	O
%	O
CI	O
)	O
that	O
were	O
adjusted	O
for	O
general	O
characteristics	O
were	O
computed	O
.	O

Arsenic	O
concentration	O
was	O
compared	O
between	O
the	O
adult	O
exposure	O
and	O
control	O
groups	O
,	O
and	O
between	O
the	O
child	O
exposure	O
group	O
and	O
adult	O
control	O
group	O
.	O

In	O
the	O
exposed	O
group	O
,	O
the	O
creatinine	O
level	O
was	O
not	O
more	O
than	O
300	O
–	O
3000	O
mg	O
/	O
L	O
.	O

In	O
the	O
control	O
group	O
,	O
creatinine	O
analysis	O
was	O
not	O
performed	O
.	O

To	O
compare	O
the	O
two	O
groups	O
,	O
we	O
used	O
the	O
value	O
before	O
creatinine	O
correction	O
.	O

The	O
GM	O
(	O
95	O
%	O
CI	O
)	O
for	O
main	O
source	O
of	O
drinking	O
water	O
was	O
computed	O
for	O
the	O
exposure	O
group	O
.	O

Additionally	O
,	O
changes	O
in	O
arsenic	O
concentration	O
between	O
the	O
first	O
and	O
second	O
assessments	O
were	O
examined	O
.	O

All	O
of	O
the	O
statistical	O
tests	O
were	O
conducted	O
at	O
a	O
significance	O
level	O
of	O
5	O
%	O
using	O
SAS	O
(	O
Version	O
9	O
.	O
4	O
,	O
SAS	O
Institute	O
,	O
Cary	O
,	O
NC	O
,	O
USA	O
).	O

2	O
.	O
6	O
Ethics	O

The	O
protocol	O
of	O
this	O
study	O
was	O
reviewed	O
and	O
approved	O
by	O
the	O
Institutional	O
Review	O
Board	O
of	O
the	O
Dong	O
-	O
A	O
university	O
hospital	O
(	O
IRB	O
No	O
.	O
13	O
-	O
010	O
).	O

Written	O
informed	O
consents	O
were	O
provided	O
by	O
all	O
of	O
the	O
participants	O
.	O

3	O
.	O

Results	O

3	O
.	O
1	O
.	O

Participant	O
Characteristics	O

Table	O
1	O
shows	O
the	O
demographic	O
and	O
lifestyle	O
characteristics	O
of	O
the	O
exposure	O
and	O
control	O
groups	O
.	O

There	O
was	O
a	O
significant	O
difference	O
in	O
sex	O
,	O
age	O
,	O
education	O
level	O
,	O
job	O
,	O
duration	O
of	O
residence	O
,	O
and	O
drinking	O
water	O
source	O
between	O
the	O
two	O
adult	O
groups	O
.	O

3	O
.	O
2	O
.	O

Comparison	O
of	O
Urinary	O
Arsenic	O
Concentrations	O

The	O
GM	O
(	O
95	O
%	O
CI	O
)	O
of	O
the	O
urinary	O
arsenic	O
concentrations	O
were	O
compared	O
after	O
adjusting	O
for	O
demographic	O
and	O
lifestyle	O
characteristics	O
in	O
addition	O
to	O
the	O
geographic	O
characteristics	O
that	O
distinguished	O
the	O
adult	O
exposure	O
and	O
control	O
groups	O
.	O

The	O
results	O
showed	O
that	O
the	O
inorganic	O
arsenic	O
concentration	O
was	O
significantly	O
higher	O
in	O
the	O
exposure	O
group	O
(	O
2	O
.	O
31	O
(	O
1	O
.	O
62	O
–	O
3	O
.	O
31	O
)	O
µg	O
/	O
L	O
)	O
than	O
in	O
the	O
control	O
group	O
(	O
0	O
.	O
94	O
(	O
0	O
.	O
61	O
–	O
1	O
.	O
44	O
)	O
µg	O
/	O
L	O
,	O
p	O
<	O
0	O
.	O
001	O
).	O

Specifically	O
,	O
a	O
significant	O
difference	O
was	O
found	O
in	O
terms	O
of	O
As	O
V	O
(	O
exposure	O
group	O
:	O
0	O
.	O
59	O
(	O
0	O
.	O
37	O
–	O
0	O
.	O
91	O
)	O
µg	O
/	O
L	O
;	O
control	O
group	O
:	O
0	O
.	O
19	O
(	O
0	O
.	O
11	O
–	O
0	O
.	O
32	O
)	O
µg	O
/	O
L	O
;	O
p	O
<	O
0	O
.	O
001	O
),	O
but	O
not	O
As	O
III	O
(	O
p	O
=	O
0	O
.	O
239	O
).	O

The	O
organic	O
arsenic	O
concentration	O
was	O
also	O
higher	O
in	O
the	O
exposure	O
group	O
than	O
in	O
the	O
control	O
group	O
(	O
exposure	O
group	O
:	O
63	O
.	O
54	O
(	O
48	O
.	O
50	O
–	O
83	O
.	O
25	O
)	O
µg	O
/	O
L	O
;	O
control	O
group	O
:	O
42	O
.	O
53	O
(	O
30	O
.	O
85	O
–	O
58	O
.	O
63	O
)	O
µg	O
/	O
L	O
;	O
p	O
=	O
0	O
.	O
007	O
).	O

A	O
significant	O
between	O
-	O
group	O
difference	O
was	O
found	O
in	O
terms	O
of	O
both	O
DMA	O
(	O
exposure	O
group	O
:	O
58	O
.	O
88	O
(	O
44	O
.	O
64	O
–	O
77	O
.	O
65	O
)	O
µg	O
/	O
L	O
;	O
control	O
group	O
:	O
39	O
.	O
68	O
(	O
28	O
.	O
56	O
–	O
55	O
.	O
14	O
)	O
µg	O
/	O
L	O
;	O
p	O
=	O
0	O
.	O
010	O
);	O
and	O
,	O
MMA	O
(	O
exposure	O
group	O
:	O
3	O
.	O
89	O
(	O
2	O
.	O
86	O
–	O
5	O
.	O
29	O
)	O
µg	O
/	O
L	O
,	O
control	O
group	O
:	O
2	O
.	O
15	O
(	O
1	O
.	O
49	O
–	O
3	O
.	O
10	O
)	O
µg	O
/	O
L	O
;	O
p	O
=	O
0	O
.	O
001	O
).	O

The	O
adjusted	O
hair	O
arsenic	O
level	O
of	O
the	O
exposure	O
group	O
was	O
0	O
.	O
19	O
(	O
0	O
.	O
15	O
–	O
0	O
.	O
24	O
)	O
ppm	O
,	O
which	O
was	O
significantly	O
higher	O
than	O
that	O
of	O
the	O
control	O
group	O
(	O
0	O
.	O
12	O
(	O
0	O
.	O
09	O
–	O
0	O
.	O
15	O
)	O
ppm	O
;	O
p	O
<	O
0	O
.	O
001	O
).	O

Urinary	O
trivalent	O
and	O
pentavalent	O
inorganic	O
arsenic	O
concentrations	O
among	O
adult	O
residents	O
were	O
1	O
.	O
04	O
µg	O
/	O
L	O
and	O
0	O
.	O
59	O
µg	O
/	O
L	O
,	O
respectively	O
,	O
which	O
were	O
significantly	O
higher	O
than	O
those	O
among	O
control	O
site	O
residents	O
(	O
0	O
.	O
71	O
µg	O
/	O
L	O
and	O
0	O
.	O
19	O
µg	O
/	O
L	O
,	O
respectively	O
).	O

Moreover	O
,	O
the	O
pentavalent	O
arsenic	O
concentration	O
of	O
the	O
children	O
in	O
this	O
region	O
was	O
1	O
.	O
29	O
µg	O
/	O
L	O
,	O
which	O
was	O
significantly	O
higher	O
than	O
that	O
among	O
control	O
site	O
residents	O
(	O
0	O
.	O
37	O
µg	O
/	O
L	O
)	O
(	O
Table	O
2	O
).	O

However	O
,	O
the	O
urinary	O
inorganic	O
arsenic	O
concentration	O
in	O
the	O
participants	O
was	O
low	O
(≤	O
10	O
µg	O
/	O
L	O
)	O
and	O
did	O
not	O
exceed	O
the	O
international	O
criteria	O
(	O
10	O
µg	O
/	O
L	O
).	O

The	O
results	O
of	O
the	O
analysis	O
conducted	O
to	O
compare	O
the	O
child	O
and	O
adult	O
exposure	O
groups	O
showed	O
that	O
the	O
GM	O
(	O
95	O
%	O
CI	O
)	O
of	O
inorganic	O
arsenic	O
was	O
2	O
.	O
03	O
(	O
1	O
.	O
75	O
–	O
2	O
.	O
37	O
)	O
µg	O
/	O
L	O
in	O
the	O
child	O
exposure	O
group	O
,	O
which	O
was	O
significantly	O
higher	O
than	O
the	O
1	O
.	O
18	O
(	O
0	O
.	O
93	O
–	O
1	O
.	O
49	O
)	O
µg	O
/	O
L	O
that	O
was	O
observed	O
in	O
the	O
control	O
group	O
.	O

Particularly	O
,	O
a	O
marked	O
difference	O
was	O
found	O
in	O
terms	O
of	O
As	O
V	O
(	O
exposure	O
group	O
:	O
1	O
.	O
29	O
(	O
1	O
.	O
16	O
–	O
1	O
.	O
44	O
)	O
µg	O
/	O
L	O
;	O
control	O
group	O
:	O
0	O
.	O
37	O
(	O
0	O
.	O
29	O
–	O
0	O
.	O
47	O
)	O
µg	O
/	O
L	O
;	O
p	O
<	O
0	O
.	O
001	O
).	O

In	O
contrast	O
,	O
the	O
organic	O
arsenic	O
concentrations	O
were	O
significantly	O
lower	O
in	O
the	O
child	O
exposure	O
group	O
than	O
in	O
the	O
control	O
group	O
(	O
exposure	O
group	O
:	O
40	O
.	O
19	O
(	O
32	O
.	O
40	O
–	O
49	O
.	O
85	O
)	O
µg	O
/	O
L	O
;	O
p	O
=	O
0	O
.	O
046	O
).	O

The	O
arsenic	O
concentration	O
in	O
hair	O
was	O
significantly	O
higher	O
in	O
the	O
child	O
exposure	O
group	O
(	O
0	O
.	O
15	O
(	O
0	O
.	O
13	O
–	O
0	O
.	O
17	O
)	O
ppm	O
)	O
than	O
in	O
the	O
control	O
group	O
(	O
0	O
.	O
10	O
(	O
0	O
.	O
09	O
–	O
0	O
.	O
11	O
)	O
ppm	O
;	O
p	O
<	O
0	O
.	O
001	O
)	O
(	O
Table	O
2	O
).	O

3	O
.	O
3	O
.	O

Urinary	O
Arsenic	O
Concentration	O
According	O
to	O
Drinking	O
Water	O
Source	O

The	O
adjusted	O
GM	O
(	O
95	O
%	O
CI	O
)	O
of	O
inorganic	O
arsenic	O
was	O
higher	O
in	O
the	O
adult	O
exposure	O
group	O
that	O
consumed	O
contaminated	O
groundwater	O
,	O
at	O
2	O
.	O
87	O
(	O
1	O
.	O
62	O
–	O
5	O
.	O
10	O
)	O
µg	O
/	O
L	O
,	O
when	O
compared	O
to	O
the	O
group	O
that	O
consumed	O
tap	O
water	O
,	O
at	O
1	O
.	O
82	O
(	O
0	O
.	O
84	O
–	O
3	O
.	O
95	O
)	O
µg	O
/	O
L	O
,	O
but	O
the	O
difference	O
was	O
not	O
statistically	O
significant	O
(	O
p	O
=	O
0	O
.	O
114	O
).	O

In	O
particular	O
,	O
the	O
concentration	O
of	O
As	O
V	O
was	O
0	O
.	O
71	O
(	O
0	O
.	O
31	O
–	O
1	O
.	O
65	O
)	O
µg	O
/	O
L	O
in	O
contaminated	O
groundwater	O
,	O
which	O
was	O
approximately	O
three	O
times	O
higher	O
than	O
that	O
in	O
tap	O
water	O
(	O
0	O
.	O
26	O
(	O
0	O
.	O
08	O
–	O
0	O
.	O
80	O
)	O
µg	O
/	O
L	O
)	O
and	O
showed	O
a	O
statistically	O
significant	O
difference	O
(	O
p	O
<	O
0	O
.	O
001	O
).	O

The	O
concentration	O
of	O
As	O
III	O
in	O
contaminated	O
groundwater	O
1	O
.	O
79	O
(	O
0	O
.	O
61	O
–	O
5	O
.	O
29	O
)	O
µg	O
/	O
L	O
was	O
more	O
than	O
twice	O
that	O
in	O
tap	O
water	O
(	O
0	O
.	O
75	O
(	O
0	O
.	O
17	O
–	O
3	O
.	O
24	O
)	O
µg	O
/	O
L	O
),	O
but	O
the	O
difference	O
was	O
not	O
statistically	O
significant	O
(	O
p	O
=	O
0	O
.	O
109	O
).	O

The	O
adjusted	O
concentration	O
of	O
organic	O
arsenic	O
in	O
contaminated	O
groundwater	O
was	O
68	O
.	O
53	O
(	O
44	O
.	O
93	O
–	O
104	O
.	O
52	O
)	O
µg	O
/	O
L	O
,	O
which	O
was	O
higher	O
than	O
that	O
in	O
tap	O
water	O
(	O
43	O
.	O
85	O
(	O
24	O
.	O
35	O
–	O
78	O
.	O
94	O
)	O
µg	O
/	O
L	O
),	O
but	O
the	O
difference	O
was	O
not	O
statistically	O
significant	O
(	O
p	O
=	O
0	O
.	O
105	O
).	O

Likewise	O
,	O
the	O
concentration	O
of	O
arsenic	O
in	O
hair	O
did	O
not	O
show	O
a	O
statistically	O
significant	O
difference	O
(	O
p	O
=	O
0	O
.	O
321	O
).	O

The	O
analysis	O
that	O
was	O
conducted	O
to	O
compare	O
arsenic	O
concentrations	O
of	O
the	O
child	O
exposure	O
group	O
according	O
to	O
source	O
of	O
drinking	O
water	O
revealed	O
that	O
the	O
inorganic	O
arsenic	O
concentration	O
was	O
2	O
.	O
09	O
(	O
1	O
.	O
73	O
–	O
2	O
.	O
52	O
)	O
µg	O
/	O
L	O
in	O
those	O
for	O
whom	O
the	O
main	O
source	O
of	O
drinking	O
water	O
was	O
contaminated	O
groundwater	O
,	O
which	O
was	O
somewhat	O
higher	O
than	O
that	O
in	O
residents	O
who	O
consumed	O
tap	O
water	O
,	O
at	O
1	O
.	O
84	O
(	O
1	O
.	O
46	O
–	O
2	O
.	O
32	O
)	O
µg	O
/	O
L	O
,	O
but	O
without	O
statistical	O
significance	O
(	O
p	O
=	O
0	O
.	O
494	O
).	O

Particularly	O
,	O
the	O
concentration	O
of	O
As	O
III	O
was	O
0	O
.	O
46	O
(	O
0	O
.	O
28	O
–	O
0	O
.	O
77	O
)	O
µg	O
/	O
L	O
in	O
contaminated	O
groundwater	O
and	O
0	O
.	O
16	O
(	O
0	O
.	O
06	O
–	O
0	O
.	O
41	O
)	O
µg	O
/	O
L	O
in	O
tap	O
water	O
,	O
indicating	O
that	O
the	O
concentration	O
of	O
the	O
former	O
was	O
more	O
than	O
twice	O
that	O
of	O
the	O
latter	O
,	O
with	O
borderline	O
significance	O
(	O
p	O
=	O
0	O
.	O
053	O
).	O

Organic	O
arsenic	O
concentration	O
did	O
not	O
show	O
a	O
statistically	O
significant	O
difference	O
between	O
these	O
groups	O
(	O
p	O
=	O
0	O
.	O
424	O
).	O

Similarly	O
,	O
there	O
was	O
no	O
statistically	O
significant	O
difference	O
in	O
the	O
concentration	O
of	O
arsenic	O
in	O
hair	O
(	O
p	O
=	O
0	O
.	O
484	O
)	O
(	O
Table	O
3	O
).	O

3	O
.	O
4	O
.	O

Changes	O
in	O
Urinary	O
Arsenic	O
Concentration	O
According	O
to	O
Timing	O
of	O
Tests	O

The	O
second	O
collection	O
of	O
urinary	O
specimens	O
was	O
performed	O
approximately	O
three	O
months	O
after	O
the	O
first	O
health	O
impact	O
survey	O
was	O
conducted	O
in	O
the	O
areas	O
exposed	O
to	O
arsenic	O
.	O

Changes	O
in	O
concentration	O
were	O
examined	O
(	O
Table	O
4	O
).	O

The	O
number	O
of	O
individuals	O
in	O
the	O
adult	O
exposure	O
group	O
whose	O
urinary	O
arsenic	O
level	O
was	O
analyzed	O
in	O
the	O
first	O
assessment	O
was	O
97	O
,	O
and	O
74	O
of	O
these	O
participants	O
were	O
followed	O
up	O
in	O
the	O
second	O
assessment	O
.	O

For	O
all	O
of	O
the	O
urinary	O
arsenic	O
species	O
,	O
including	O
inorganic	O
arsenic	O
,	O
the	O
concentration	O
was	O
lower	O
in	O
the	O
second	O
assessment	O
than	O
that	O
in	O
the	O
first	O
.	O

The	O
concentration	O
of	O
inorganic	O
arsenic	O
decreased	O
by	O
2	O
.	O
19	O
µg	O
/	O
L	O
±	O
1	O
.	O
90	O
µg	O
/	O
L	O
,	O
and	O
it	O
was	O
below	O
the	O
limit	O
of	O
detection	O
in	O
most	O
of	O
the	O
participants	O
(	O
p	O
<	O
0	O
.	O
001	O
).	O

Specifically	O
,	O
the	O
concentration	O
of	O
As	O
V	O
decreased	O
by	O
0	O
.	O
93	O
µg	O
/	O
L	O
±	O
0	O
.	O
90	O
µg	O
/	O
L	O
and	O
As	O
III	O
by	O
1	O
.	O
27	O
µg	O
/	O
L	O
±	O
1	O
.	O
59	O
µg	O
/	O
L	O
,	O
with	O
both	O
values	O
demonstrating	O
statistically	O
significant	O
differences	O
(	O
p	O
<	O
0	O
.	O
001	O
).	O

Likewise	O
,	O
the	O
concentration	O
of	O
organic	O
arsenic	O
decreased	O
by	O
12	O
.	O
54	O
µg	O
/	O
L	O
±	O
69	O
.	O
97	O
µg	O
/	O
L	O
(	O
p	O
=	O
0	O
.	O
127	O
).	O

In	O
particular	O
,	O
the	O
concentration	O
of	O
MMA	O
decreased	O
by	O
1	O
.	O
58	O
µg	O
/	O
L	O
±	O
3	O
.	O
73	O
µg	O
/	O
L	O
,	O
showing	O
a	O
statistically	O
significant	O
difference	O
(	O
p	O
<	O
0	O
.	O
001	O
).	O

The	O
arsenic	O
concentration	O
decreased	O
from	O
the	O
first	O
assessment	O
to	O
the	O
second	O
in	O
98	O
.	O
7	O
%	O
of	O
participants	O
,	O
with	O
the	O
exception	O
of	O
1	O
.	O
4	O
%	O
in	O
whom	O
the	O
inorganic	O
arsenic	O
concentration	O
remained	O
the	O
same	O
,	O
and	O
the	O
mean	O
decrease	O
was	O
2	O
.	O
22	O
µg	O
/	O
L	O
±	O
1	O
.	O
89	O
µg	O
/	O
L	O
.	O

The	O
number	O
of	O
individuals	O
in	O
the	O
child	O
exposure	O
group	O
whose	O
urinary	O
arsenic	O
level	O
was	O
examined	O
during	O
the	O
first	O
assessment	O
was	O
45	O
,	O
and	O
all	O
of	O
them	O
were	O
followed	O
up	O
during	O
the	O
second	O
assessment	O
.	O

The	O
mean	O
difference	O
in	O
organic	O
arsenic	O
concentration	O
between	O
the	O
first	O
and	O
second	O
assessment	O
was	O
5	O
.	O
93	O
µg	O
/	O
L	O
±	O
45	O
.	O
29	O
µg	O
/	O
L	O
,	O
indicating	O
a	O
slight	O
increase	O
,	O
but	O
statistical	O
significance	O
was	O
not	O
achieved	O
(	O
p	O
=	O
0	O
.	O
385	O
).	O

The	O
concentration	O
of	O
inorganic	O
arsenic	O
reduced	O
by	O
1	O
.	O
94	O
µg	O
/	O
L	O
±	O
1	O
.	O
21	O
µg	O
/	O
L	O
,	O
and	O
was	O
below	O
the	O
limit	O
of	O
detection	O
in	O
almost	O
all	O
of	O
the	O
participants	O
(	O
p	O
<	O
0	O
.	O
001	O
).	O

Specifically	O
,	O
the	O
concentration	O
of	O
As	O
V	O
decreased	O
by	O
1	O
.	O
17	O
µg	O
/	O
L	O
±	O
0	O
.	O
65	O
µg	O
/	O
L	O
and	O
As	O
III	O
by	O
0	O
.	O
76	O
µg	O
/	O
L	O
±	O
1	O
.	O
01	O
µg	O
/	O
L	O
,	O
and	O
the	O
decrease	O
was	O
statistically	O
significant	O
(	O
p	O
<	O
0	O
.	O
001	O
).	O

The	O
concentration	O
of	O
inorganic	O
arsenic	O
was	O
confirmed	O
to	O
have	O
decreased	O
from	O
the	O
first	O
assessment	O
to	O
the	O
second	O
in	O
all	O
participants	O
.	O

3	O
.	O
5	O
.	O

Comparison	O
of	O
the	O
Diagnostic	O
Test	O
Results	O
among	O
Adult	O
Participants	O

Most	O
health	O
screening	O
results	O
did	O
not	O
show	O
a	O
statistically	O
significant	O
difference	O
between	O
groups	O
,	O
but	O
systolic	O
blood	O
pressure	O
,	O
white	O
blood	O
cell	O
count	O
,	O
and	O
carbohydrate	O
antigen	O
19	O
-	O
9	O
(	O
marker	O
of	O
pancreatic	B-DS
cancer	I-DS
)	O
level	O
showed	O
a	O
statistically	O
significant	O
difference	O
.	O

However	O
,	O
systolic	O
blood	O
pressure	O
and	O
white	O
blood	O
cell	O
count	O
were	O
higher	O
in	O
the	O
control	O
group	O
,	O
while	O
carbohydrate	O
antigen	O
19	O
-	O
9	O
level	O
was	O
higher	O
in	O
the	O
exposure	O
group	O
.	O

Nevertheless	O
,	O
most	O
of	O
the	O
results	O
fell	O
within	O
the	O
normal	O
range	O
(	O
Table	O
5	O
).	O

3	O
.	O
6	O
.	O

Changes	O
in	O
Arsenic	O
Concentration	O
in	O
the	O
Water	O
Supply	O
in	O
the	O
Exposure	O
Areas	O

The	O
concentration	O
of	O
arsenic	O
in	O
the	O
drinking	O
water	O
of	O
the	O
studied	O
area	O
was	O
much	O
higher	O
than	O
the	O
Korean	O
drinking	O
water	O
standard	O
(	O
0	O
.	O
010	O
mg	O
/	O
L	O
)	O
at	O
0	O
.	O
018	O
–	O
0	O
.	O
104	O
mg	O
/	O
L	O
.	O

The	O
data	O
obtained	O
from	O
the	O
second	O
screening	O
showed	O
a	O
very	O
similar	O
range	O
:	O
0	O
.	O
016	O
–	O
0	O
.	O
097	O
mg	O
/	O
L	O
.	O

However	O
,	O
the	O
local	O
government	O
installed	O
a	O
drinking	O
water	O
filter	O
for	O
arsenic	O
soon	O
after	O
they	O
recognized	O
the	O
water	O
contamination	O
.	O

Subsequently	O
,	O
the	O
concentration	O
of	O
arsenic	O
decreased	O
to	O
below	O
0	O
.	O
01	O
mg	O
/	O
L	O
(	O
Table	O
6	O
).	O

3	O
.	O
7	O
.	O

Arsenic	O
Concentration	O
in	O
the	O
Soil	O
and	O
Crops	O
Surrounding	O
the	O
Exposure	O
Areas	O

The	O
arsenic	O
concentration	O
in	O
farmland	O
soil	O
ranged	O
5	O
.	O
27	O
–	O
16	O
.	O
37	O
mg	O
/	O
kg	O
(	O
Table	O
7	O
),	O
which	O
was	O
below	O
the	O
Korean	O
soil	O
environmental	O
limit	O
of	O
25	O
mg	O
/	O
kg	O
.	O

The	O
arsenic	O
concentration	O
in	O
rice	O
samples	O
ranged	O
0	O
.	O
03	O
–	O
0	O
.	O
212	O
mg	O
/	O
kg	O
,	O
which	O
was	O
below	O
the	O
Korean	O
food	O
environmental	O
limit	O
of	O
0	O
.	O
2	O
mg	O
/	O
kg	O
.	O

4	O
.	O

Discussion	O

The	O
present	O
environmental	O
impact	O
assessment	O
survey	O
showed	O
that	O
the	O
concentration	O
of	O
arsenic	O
in	O
the	O
drinking	O
water	O
of	O
the	O
studied	O
area	O
ranged	O
18	O
–	O
104	O
µg	O
/	O
L	O
,	O
which	O
was	O
much	O
higher	O
than	O
the	O
Korean	O
drinking	O
water	O
standard	O
of	O
10	O
µg	O
/	O
L	O
.	O

The	O
data	O
obtained	O
at	O
the	O
second	O
screening	O
stage	O
showed	O
a	O
very	O
similar	O
trend	O
:	O
16	O
–	O
97	O
µg	O
/	O
L	O
.	O

This	O
indicates	O
that	O
water	O
containing	O
arsenic	O
concentrations	O
above	O
the	O
standard	O
value	O
has	O
been	O
supplied	O
as	O
drinking	O
water	O
for	O
a	O
few	O
hundred	O
local	O
residents	O
.	O

Based	O
on	O
the	O
geographic	O
characteristic	O
of	O
the	O
studied	O
area	O
,	O
we	O
presume	O
that	O
the	O
contaminated	O
water	O
has	O
been	O
supplied	O
for	O
a	O
few	O
years	O
after	O
the	O
small	O
-	O
scale	O
water	O
supply	O
system	O
has	O
been	O
installed	O
;	O
however	O
,	O
we	O
do	O
not	O
have	O
sufficient	O
data	O
to	O
confirm	O
this	O
.	O

Nonetheless	O
,	O
the	O
local	O
government	O
installed	O
a	O
drinking	O
water	O
filter	O
for	O
arsenic	O
soon	O
after	O
they	O
recognized	O
the	O
water	O
contamination	O
.	O

Subsequently	O
,	O
the	O
concentration	O
of	O
arsenic	O
related	O
decreased	O
to	O
below	O
10	O
µg	O
/	O
L	O
.	O

The	O
current	O
study	O
was	O
initiated	O
>	O
2	O
months	O
after	O
the	O
filter	O
installation	O
.	O

Generally	O
,	O
arsenic	O
toxicity	O
is	O
caused	O
by	O
the	O
exposure	O
to	O
high	O
levels	O
of	O
arsenic	O
(>	O
100	O
µg	O
/	O
L	O
),	O
and	O
has	O
shown	O
a	O
significant	O
association	O
with	O
skin	B-DS
cancer	I-DS
,	O
lung	B-DS
cancer	I-DS
,	O
bladder	B-DS
cancer	I-DS
,	O
and	O
non	O
-	O
carcinogenic	O
effects	O
[	O
20	O
,	O
21	O
,	O
22	O
,	O
23	O
].	O

The	O
non	O
-	O
carcinogenic	O
effect	O
has	O
been	O
reported	O
to	O
include	O
human	B-OG
effects	O
that	O
are	O
caused	O
by	O
ingestion	O
of	O
inorganic	O
arsenic	O
,	O
including	O
mucous	O
membrane	O
stimulation	O
and	O
skin	B-DS
lesions	I-DS
,	O
peripheral	O
neurotoxicity	O
,	O
keratosis	B-DS
,	O
neuromuscular	O
abnormalities	O
,	O
and	O
vascular	O
abnormalities	O
[	O
24	O
].	O

Brown	O
et	O
al	O
.	O
[	O
25	O
]	O
suggested	O
the	O
lifetime	O
risk	O
of	O
developing	O
skin	B-DS
cancer	I-DS
was	O
1	O
.	O
3	O
/	O
1000	O
for	O
males	O
and	O
0	O
.	O
6	O
/	O
1000	O
for	O
females	O
per	O
microgram	O
of	O
arsenic	O
per	O
day	O
in	O
Taiwan	O
.	O

Moreover	O
,	O
the	O
regression	O
analysis	O
showed	O
that	O
the	O
cancer	B-DS
mortality	O
rate	O
(	O
per	O
100	O
,	O
000	O
)	O
for	O
bladder	O
,	O
kidney	O
,	O
lung	O
,	O
and	O
liver	B-DS
cancer	I-DS
significantly	O
increased	O
per	O
microgram	O
increase	O
in	O
arsenic	O
exposure	O
via	O
drinking	O
water	O
in	O
a	O
linear	O
dose	O
-	O
response	O
.	O

Abernathy	O
et	O
al	O
.	O
[	O
26	O
]	O
suggested	O
the	O
NOAEL	O
0	O
.	O
8	O
µg	O
/	O
kg	O
/	O
day	O
,	O
LOAEL	O
14	O
µg	O
/	O
kg	O
/	O
day	O
using	O
the	O
Tseng	O
et	O
al	O
.	O
[	O
27	O
]	O
and	O
Tseng	O
model	O
[	O
28	O
].	O

In	O
the	O
United	O
States	O
of	O
America	O
(	O
USA	O
),	O
the	O
estimated	O
lifetime	O
risk	O
of	O
dying	O
from	O
cancer	B-DS
due	O
to	O
arsenic	O
exposure	O
via	O
drinking	O
water	O
(	O
1	O
.	O
6	O
L	O
/	O
day	O
)	O
was	O
1	O
/	O
1000	O
per	O
2	O
.	O
5	O
microgram	O
of	O
arsenic	O
exposure	O
per	O
day	O
[	O
29	O
].	O

Therefore	O
,	O
the	O
possibility	O
of	O
disease	O
is	O
related	O
to	O
the	O
amount	O
of	O
exposure	O
.	O

When	O
considering	O
the	O
elevated	O
arsenic	O
concentrations	O
,	O
it	O
may	O
not	O
be	O
sufficient	O
to	O
cause	O
detectable	O
health	O
effects	O
in	O
a	O
period	O
of	O
less	O
than	O
one	O
year	O
,	O
however	O
,	O
lifetime	O
assessment	O
should	O
be	O
conducted	O
in	O
future	O
study	O
.	O

We	O
presume	O
that	O
the	O
elevated	O
arsenic	O
concentrations	O
may	O
not	O
be	O
sufficient	O
to	O
cause	O
detectable	O
health	O
effects	O
in	O
a	O
period	O
of	O
less	O
than	O
one	O
year	O
,	O
however	O
,	O
human	B-OG
exposure	O
of	O
arsenic	O
could	O
occur	O
via	O
other	O
chemical	O
exposure	O
pathways	O
,	O
including	O
ingestion	O
of	O
contaminated	O
residential	O
soil	O
,	O
inhalation	O
of	O
soil	O
dust	O
,	O
dermal	O
contact	O
to	O
the	O
residential	O
soil	O
[	O
30	O
],	O
and	O
ingestion	O
of	O
contaminated	O
agricultural	O
foods	O
[	O
31	O
].	O

Therefore	O
,	O
it	O
will	O
be	O
necessary	O
to	O
assess	O
the	O
health	O
effects	O
of	O
multiple	O
exposures	O
when	O
considering	O
these	O
factors	O
in	O
the	O
future	O
.	O

One	O
of	O
the	O
limitations	O
of	O
this	O
study	O
was	O
that	O
we	O
did	O
not	O
select	O
a	O
child	O
control	O
group	O
.	O

It	O
was	O
difficult	O
to	O
obtain	O
control	O
children	O
who	O
met	O
the	O
conditions	O
to	O
living	O
condition	O
,	O
age	O
distribution	O
,	O
and	O
time	O
and	O
budget	O
constraints	O
.	O

Although	O
the	O
adult	O
control	O
group	O
was	O
not	O
satisfied	O
as	O
a	O
case	O
-	O
control	O
in	O
comparison	O
with	O
the	O
children	O
exposure	O
group	O
,	O
it	O
was	O
used	O
as	O
a	O
reference	O
to	O
compare	O
the	O
concentration	O
of	O
inorganic	O
arsenic	O
that	O
was	O
exposed	O
to	O
contaminated	O
water	O
.	O

Our	O
community	O
-	O
based	O
health	O
survey	O
showed	O
that	O
the	O
urinary	O
organic	O
and	O
inorganic	O
arsenic	O
concentrations	O
among	O
residents	O
were	O
significantly	O
higher	O
than	O
those	O
of	O
control	O
site	O
residents	O
;	O
moreover	O
,	O
the	O
consumption	O
of	O
contaminated	O
drinking	O
water	O
was	O
found	O
to	O
urinary	O
arsenic	O
concentration	O
in	O
residents	O
.	O

When	O
considering	O
that	O
the	O
current	O
study	O
was	O
initiated	O
>	O
2	O
months	O
after	O
the	O
installation	O
of	O
the	O
filter	O
by	O
the	O
local	O
government	O
,	O
and	O
that	O
the	O
half	O
-	O
life	O
of	O
inorganic	O
arsenic	O
in	O
the	O
body	O
is	O
approximately	O
2	O
–	O
4	O
days	O
,	O
the	O
level	O
of	O
arsenic	O
exposure	O
among	O
residents	O
in	O
the	O
past	O
was	O
higher	O
than	O
that	O
recorded	O
in	O
the	O
present	O
study	O
[	O
32	O
].	O

Recent	O
reports	O
have	O
shown	O
that	O
exposure	O
to	O
low	O
concentrations	O
of	O
arsenic	O
could	O
result	O
in	O
high	B-DS
blood	I-DS
pressure	I-DS
,	O
obesity	B-DS
,	O
high	O
triglyceride	O
,	O
hyperglycemia	B-DS
,	O
metabolic	B-DS
syndrome	I-DS
,	O
anemia	B-DS
,	O
and	O
bone	O
damage	O
[	O
33	O
,	O
34	O
,	O
35	O
,	O
36	O
].	O

We	O
evaluated	O
the	O
carcinogenic	O
and	O
non	O
-	O
carcinogenic	O
effects	O
arsenic	O
exposure	O
;	O
however	O
,	O
we	O
did	O
not	O
find	O
any	O
carcinogenic	O
or	O
obvious	O
clinical	O
abnormalities	O
among	O
exposure	O
residents	O
when	O
compared	O
with	O
the	O
control	O
subjects	O
.	O

In	O
this	O
study	O
,	O
we	O
applied	O
the	O
tumor	B-DS
marker	O
test	O
to	O
evaluate	O
the	O
carcinogenicity	O
of	O
arsenic	O
,	O
although	O
it	O
is	O
a	O
nonspecific	O
test	O
for	O
cancer	B-DS
screening	O
.	O

We	O
selected	O
tumor	B-DS
marker	O
liver	O
,	O
colon	O
,	O
pancreas	O
,	O
ovary	O
,	O
prostate	O
,	O
and	O
lung	O
that	O
carcinogenicity	O
may	O
be	O
associated	O
with	O
the	O
inorganic	O
arsenic	O
exposure	O
.	O

As	O
a	O
result	O
of	O
analysis	O
,	O
one	O
subject	O
who	O
exceeded	O
the	O
reference	O
value	O
in	O
Carbohydrate	O
antigen	O
19	O
-	O
9	O
was	O
found	O
,	O
but	O
there	O
was	O
no	O
clinical	O
relevance	O
according	O
to	O
the	O
exposure	O
of	O
arsenic	O
through	O
close	O
examination	O
.	O

All	O
of	O
the	O
subjects	O
were	O
within	O
normal	O
range	O
and	O
there	O
was	O
no	O
statistically	O
significant	O
difference	O
between	O
the	O
exposure	O
and	O
control	O
group	O
.	O

In	O
general	O
,	O
this	O
clinical	O
tumor	B-DS
marker	O
test	O
is	O
more	O
applicable	O
to	O
follow	O
up	O
cancer	B-DS
management	O
than	O
cancer	B-DS
screening	O
.	O

Therefore	O
,	O
it	O
is	O
considered	O
to	O
be	O
worthy	O
of	O
a	O
reference	O
test	O
rather	O
than	O
a	O
detection	O
of	O
cancer	B-DS
development	O
due	O
to	O
arsenic	O
exposure	O
.	O

5	O
.	O

Conclusions	O

We	O
presume	O
that	O
the	O
elevated	O
arsenic	O
concentrations	O
may	O
not	O
be	O
sufficient	O
to	O
cause	O
detectable	O
health	O
effects	O
.	O

Moreover	O
,	O
we	O
analyzed	O
these	O
subjects	O
for	O
relatively	O
short	O
period	O
.	O

We	O
also	O
found	O
that	O
the	O
consumption	O
of	O
arsenic	O
contaminated	O
groundwater	O
could	O
elevate	O
urinary	O
organic	O
and	O
inorganic	O
arsenic	O
concentrations	O
.	O

Therefore	O
,	O
the	O
consumption	O
of	O
arsenic	O
contaminated	O
groundwater	O
poses	O
a	O
health	O
threat	O
to	O
the	O
residents	O
of	O
the	O
study	O
area	O
.	O

We	O
recommend	O
immediate	O
discontinuation	O
of	O
groundwater	O
supply	O
in	O
this	O
area	O
for	O
the	O
safety	O
of	O
the	O
residents	O
.	O

Nonetheless	O
,	O
urinary	O
inorganic	O
arsenic	O
level	O
was	O
found	O
to	O
decrease	O
dramatically	O
overtime	O
.	O

This	O
study	O
has	O
several	O
limitations	O
.	O

First	O
,	O
it	O
was	O
difficult	O
to	O
accurately	O
compare	O
arsenic	O
exposure	O
concentrations	O
before	O
and	O
after	O
the	O
introduction	O
of	O
the	O
arsenic	O
filtration	O
system	O
,	O
since	O
this	O
study	O
was	O
conducted	O
after	O
the	O
arsenic	O
filtration	O
systems	O
were	O
installed	O
.	O

Second	O
,	O
we	O
did	O
not	O
perform	O
the	O
urinary	O
creatinine	O
normalization	O
of	O
arsenic	O
in	O
the	O
comparison	O
between	O
exposed	O
and	O
control	O
group	O
.	O

Nevertheless	O
,	O
the	O
findings	O
of	O
this	O
survey	O
are	O
important	O
for	O
policy	O
making	O
in	O
Korea	O
.	O

This	O
is	O
the	O
first	O
epidemiological	O
survey	O
of	O
arsenic	O
contamination	O
of	O
drinking	O
water	O
in	O
Korea	O
.	O

Moreover	O
,	O
this	O
survey	O
could	O
bring	O
about	O
cooperation	O
among	O
community	O
residents	O
,	O
non	O
-	O
governmental	O
organization	O
,	O
and	O
the	O
local	O
government	O
without	O
the	O
support	O
of	O
government	O
.	O

We	O
believe	O
these	O
findings	O
could	O
serve	O
as	O
important	O
evidence	O
for	O
the	O
management	O
of	O
exposure	O
to	O
arsenic	O
-	O
contaminated	O
groundwater	O
.	O

Survey	O
flow	O
.	O

Participant	O
characteristics	O
.	O

Characteristics	O

Adult	O

p	O
-	O
Value	O

Child	O
Exposure	O
(	O
Age	O
≤	O
12	O
)	O

Exposure	O

Control	O

Total	O

99	O
(	O
60	O
.	O
4	O
)	O

65	O
(	O
39	O
.	O
6	O
)	O

45	O

Sex	O

Male	O

35	O
(	O
35	O
.	O
4	O
)	O

12	O
(	O
18	O
.	O
5	O
)	O

0	O
.	O
019	O

24	O
(	O
53	O
.	O
3	O
)	O

Female	O

64	O
(	O
64	O
.	O
6	O
)	O

53	O
(	O
81	O
.	O
5	O
)	O

21	O
(	O
46	O
.	O
7	O
)	O

Age	O
(	O
year	O
)	O

Mean	O
±	O
Standard	O
deviation	O

62	O
.	O
87	O
±	O
15	O
.	O
29	O

66	O
.	O
58	O
±	O
8	O
.	O
03	O

0	O
.	O
073	O

7	O
.	O
69	O
±	O
2	O
.	O
44	O

19	O
–	O
49	O

15	O
(	O
15	O
.	O
2	O
)	O

1	O
(	O
1	O
.	O
5	O
)	O

0	O
.	O
001	O

50	O
–	O
59	O

24	O
(	O
24	O
.	O
2	O
)	O

10	O
(	O
15	O
.	O
4	O
)	O

60	O
–	O
69	O

20	O
(	O
20	O
.	O
2	O
)	O

30	O
(	O
46	O
.	O
2	O
)	O

≥	O
70	O

40	O
(	O
40	O
.	O
4	O
)	O

24	O
(	O
36	O
.	O
9	O
)	O

Education	O
level	O
(	O
year	O
)	O

Less	O
than	O
elementary	O
school	O
(<	O
6	O
)	O

23	O
(	O
23	O
.	O
2	O
)	O

15	O
(	O
23	O
.	O
8	O
)	O

0	O
.	O
012	O

Elementary	O
school	O
(	O
6	O
–	O
9	O
)	O

18	O
(	O
18	O
.	O
2	O
)	O

19	O
(	O
30	O
.	O
2	O
)	O

Middle	O
school	O
(	O
9	O
–	O
12	O
)	O

16	O
(	O
16	O
.	O
2	O
)	O

17	O
(	O
27	O
.	O
0	O
)	O

High	O
school	O
and	O
more	O
(≥	O
13	O
)	O

42	O
(	O
42	O
.	O
4	O
)	O

12	O
(	O
19	O
.	O
0	O
)	O

Smoking	O
status	O

Current	O
-	O
smoker	O

11	O
(	O
11	O
.	O
1	O
)	O

2	O
(	O
3	O
.	O
1	O
)	O

0	O
.	O
173	O

Former	O
-	O
smoker	O

15	O
(	O
15	O
.	O
2	O
)	O

10	O
(	O
15	O
.	O
4	O
)	O

Never	O
-	O
smoker	O

73	O
(	O
73	O
.	O
7	O
)	O

53	O
(	O
81	O
.	O
5	O
)	O

Drinking	O
status	O

Current	O
-	O
drinking	O

52	O
(	O
52	O
.	O
5	O
)	O

32	O
(	O
49	O
.	O
2	O
)	O

0	O
.	O
085	O

Former	O
-	O
drinking	O

13	O
(	O
13	O
.	O
1	O
)	O

17	O
(	O
26	O
.	O
2	O
)	O

Never	O
-	O
drinking	O

34	O
(	O
34	O
.	O
3	O
)	O

16	O
(	O
24	O
.	O
6	O
)	O

Job	O

Skilled	O
agricultural	O
workers	O

33	O
(	O
33	O
.	O
3	O
)	O

49	O
(	O
75	O
.	O
4	O
)	O

<	O
0	O
.	O
001	O

The	O
others	O

66	O
(	O
66	O
.	O
7	O
)	O

16	O
(	O
24	O
.	O
6	O
)	O

Duration	O
of	O
residence	O
(	O
year	O
)	O
(	O
missing	O
n	O
=	O
8	O
in	O
exp	O
)(	O
missing	O
n	O
=	O
8	O
in	O
ctrl	O
)	O

Mean	O
±	O
Standard	O
deviation	O

37	O
.	O
05	O
±	O
24	O
.	O
69	O

41	O
.	O
07	O
±	O
19	O
.	O
20	O

0	O
.	O
298	O

≤	O
20	O

34	O
(	O
37	O
.	O
4	O
)	O

10	O
(	O
17	O
.	O
5	O
)	O

0	O
.	O
005	O

21	O
–	O
50	O

23	O
(	O
25	O
.	O
3	O
)	O

28	O
(	O
49	O
.	O
1	O
)	O

≥	O
51	O

34	O
(	O
37	O
.	O
4	O
)	O

19	O
(	O
33	O
.	O
3	O
)	O

Drinking	O
water	O

Tap	O
water	O

16	O
(	O
16	O
.	O
2	O
)	O

60	O
(	O
92	O
.	O
3	O
)	O

<	O
0	O
.	O
001	O

10	O
(	O
22	O
.	O
2	O
)	O

Mineral	O
water	O

6	O
(	O
6	O
.	O
1	O
)	O

0	O
(	O
0	O
.	O
0	O
)	O

0	O
(	O
0	O
.	O
0	O
)	O

Contaminated	O
groundwater	O

77	O
(	O
77	O
.	O
8	O
)	O

5	O
(	O
7	O
.	O
7	O
)	O

35	O
(	O
77	O
.	O
8	O
)	O

Comparison	O
of	O
arsenic	O
concentrations	O
.	O

Arsenic	O
Species	O
in	O
Urine	O
and	O
Hair	O

GM	O
(	O
95	O
%	O
CI	O
)	O

p	O
-	O
Value	O
1	O

p	O
-	O
Value	O
2	O

Exposure	O

Control	O
(	O
n	O
=	O
64	O
)	O

Adult	O
(	O
n	O
=	O
97	O
)	O

Child	O
(	O
n	O
=	O
45	O
)	O

Crude	O

Urine	O
(	O
µg	O
/	O
L	O
)	O

Organic	O
As	O

DMA	O

57	O
.	O
445	O
(	O
49	O
.	O
289	O
–	O
66	O
.	O
949	O
)	O

37	O
.	O
160	O
(	O
29	O
.	O
820	O
–	O
46	O
.	O
305	O
)	O

51	O
.	O
179	O
(	O
41	O
.	O
652	O
–	O
62	O
.	O
884	O
)	O

0	O
.	O
363	O

0	O
.	O
039	O

MMA	O

3	O
.	O
620	O
(	O
3	O
.	O
030	O
–	O
4	O
.	O
325	O
)	O

2	O
.	O
361	O
(	O
1	O
.	O
741	O
–	O
3	O
.	O
203	O
)	O

2	O
.	O
549	O
(	O
2	O
.	O
037	O
–	O
3	O
.	O
188	O
)	O

0	O
.	O
015	O

0	O
.	O
680	O

Subtotal	O

61	O
.	O
781	O
(	O
53	O
.	O
156	O
–	O
71	O
.	O
804	O
)	O

40	O
.	O
190	O
(	O
32	O
.	O
405	O
–	O
49	O
.	O
846	O
)	O

54	O
.	O
396	O
(	O
44	O
.	O
463	O
–	O
66	O
.	O
548	O
)	O

0	O
.	O
307	O

0	O
.	O
046	O

Inorganic	O
As	O

As	O
III	O

0	O
.	O
778	O
(	O
0	O
.	O
556	O
–	O
1	O
.	O
087	O
)	O

0	O
.	O
366	O
(	O
0	O
.	O
233	O
–	O
0	O
.	O
576	O
)	O

0	O
.	O
586	O
(	O
0	O
.	O
419	O
–	O
0	O
.	O
819	O
)	O

0	O
.	O
256	O

0	O
.	O
090	O

As	O
V	O

0	O
.	O
736	O
(	O
0	O
.	O
566	O
–	O
0	O
.	O
956	O
)	O

1	O
.	O
294	O
(	O
1	O
.	O
160	O
–	O
1	O
.	O
442	O
)	O

0	O
.	O
366	O
(	O
0	O
.	O
286	O
–	O
0	O
.	O
467	O
)	O

<	O
0	O
.	O
001	O

<	O
0	O
.	O
001	O

Subtotal	O

2	O
.	O
144	O
(	O
1	O
.	O
752	O
–	O
2	O
.	O
624	O
)	O

2	O
.	O
034	O
(	O
1	O
.	O
748	O
–	O
2	O
.	O
366	O
)	O

1	O
.	O
176	O
(	O
0	O
.	O
928	O
–	O
1	O
.	O
491	O
)	O

<	O
0	O
.	O
001	O

<	O
0	O
.	O
001	O

Total	O

64	O
.	O
561	O
(	O
55	O
.	O
617	O
–	O
74	O
.	O
942	O
)	O

56	O
.	O
052	O
(	O
45	O
.	O
904	O
–	O
68	O
.	O
444	O
)	O

0	O
.	O
253	O

0	O
.	O
065	O

Hair	O
(	O
ppm	O
)	O
Exposure	O
n	O
=	O
98Control	O
n	O
=	O
65	O

0	O
.	O
161	O
(	O
0	O
.	O
138	O
–	O
0	O
.	O
186	O
)	O

0	O
.	O
097	O
(	O
0	O
.	O
085	O
–	O
0	O
.	O
111	O
)	O

<	O
0	O
.	O
001	O

<	O
0	O
.	O
001	O

Adjusted	O

Urine	O
(	O
µg	O
/	O
L	O
)	O

Organic	O
As	O

DMA	O

58	O
.	O
880	O
(	O
44	O
.	O
644	O
–	O
77	O
.	O
654	O
)	O

39	O
.	O
682	O
(	O
28	O
.	O
559	O
–	O
55	O
.	O
136	O
)	O

0	O
.	O
010	O

MMA	O

3	O
.	O
890	O
(	O
2	O
.	O
861	O
–	O
5	O
.	O
289	O
)	O

2	O
.	O
149	O
(	O
1	O
.	O
492	O
–	O
3	O
.	O
096	O
)	O

0	O
.	O
001	O

Subtotal	O

63	O
.	O
543	O
(	O
48	O
.	O
500	O
–	O
83	O
.	O
252	O
)	O

42	O
.	O
527	O
(	O
30	O
.	O
848	O
–	O
58	O
.	O
627	O
)	O

0	O
.	O
007	O

Inorganic	O
As	O

As	O
III	O

1	O
.	O
035	O
(	O
0	O
.	O
573	O
–	O
1	O
.	O
870	O
)	O

0	O
.	O
706	O
(	O
0	O
.	O
350	O
–	O
1	O
.	O
426	O
)	O

0	O
.	O
239	O

As	O
V	O

0	O
.	O
585	O
(	O
0	O
.	O
374	O
–	O
0	O
.	O
915	O
)	O

0	O
.	O
190	O
(	O
0	O
.	O
112	O
–	O
0	O
.	O
323	O
)	O

<	O
0	O
.	O
001	O

Subtotal	O

2	O
.	O
314	O
(	O
1	O
.	O
616	O
–	O
3	O
.	O
314	O
)	O

0	O
.	O
937	O
(	O
0	O
.	O
611	O
–	O
1	O
.	O
435	O
)	O

<	O
0	O
.	O
001	O

Total	O

66	O
.	O
558	O
(	O
50	O
.	O
954	O
–	O
86	O
.	O
940	O
)	O

43	O
.	O
920	O
(	O
31	O
.	O
973	O
–	O
60	O
.	O
332	O
)	O

0	O
.	O
005	O

Hair	O
(	O
ppm	O
)	O

0	O
.	O
187	O
(	O
0	O
.	O
149	O
–	O
0	O
.	O
226	O
)	O

0	O
.	O
117	O
(	O
0	O
.	O
089	O
–	O
0	O
.	O
154	O
)	O

<	O
0	O
.	O
001	O

Comparison	O
of	O
arsenic	O
concentrations	O
between	O
the	O
adult	O
and	O
child	O
exposure	O
groups	O
according	O
to	O
source	O
of	O
drinking	O
water	O
.	O

Arsenic	O
Species	O
in	O
Urine	O
and	O
Hair	O

Adjusted	O
GM	O
(	O
95	O
%	O
CI	O
)	O

p	O
-	O
Value	O

Contaminated	O
Ground	O
Water	O
(	O
n	O
=	O
66	O
)	O

Tap	O
Water	O
(	O
n	O
=	O
14	O
)	O

Adult	O

Urine	O
(	O
µg	O
/	O
L	O
)	O

Organic	O
As	O

DMA	O

62	O
.	O
487	O
(	O
40	O
.	O
451	O
–	O
96	O
.	O
527	O
)	O

43	O
.	O
845	O
(	O
24	O
.	O
353	O
–	O
78	O
.	O
939	O
)	O

0	O
.	O
105	O

MMA	O

5	O
.	O
532	O
(	O
3	O
.	O
762	O
–	O
8	O
.	O
134	O
)	O

3	O
.	O
999	O
(	O
2	O
.	O
375	O
–	O
6	O
.	O
735	O
)	O

0	O
.	O
094	O

Subtotal	O

68	O
.	O
531	O
(	O
44	O
.	O
933	O
–	O
104	O
.	O
521	O
)	O

48	O
.	O
222	O
(	O
27	O
.	O
250	O
–	O
85	O
.	O
332	O
)	O

0	O
.	O
098	O

Inorganic	O
As	O

As	O
III	O

1	O
.	O
791	O
(	O
0	O
.	O
606	O
–	O
5	O
.	O
294	O
)	O

0	O
.	O
748	O
(	O
0	O
.	O
173	O
–	O
3	O
.	O
238	O
)	O

0	O
.	O
109	O

As	O
V	O

0	O
.	O
710	O
(	O
0	O
.	O
307	O
–	O
1	O
.	O
646	O
)	O

0	O
.	O
256	O
(	O
0	O
.	O
082	O
–	O
0	O
.	O
797	O
)	O

0	O
.	O
017	O

Subtotal	O

2	O
.	O
871	O
(	O
1	O
.	O
617	O
–	O
5	O
.	O
097	O
)	O

1	O
.	O
819	O
(	O
0	O
.	O
837	O
–	O
3	O
.	O
953	O
)	O

0	O
.	O
114	O

Total	O

72	O
.	O
118	O
(	O
47	O
.	O
556	O
–	O
109	O
.	O
364	O
)	O

50	O
.	O
665	O
(	O
28	O
.	O
853	O
–	O
88	O
.	O
965	O
)	O

0	O
.	O
092	O

Hair	O
(	O
ppm	O
)	O

0	O
.	O
157	O
(	O
0	O
.	O
102	O
–	O
0	O
.	O
241	O
)	O

0	O
.	O
127	O
(	O
0	O
.	O
071	O
–	O
0	O
.	O
226	O
)	O

0	O
.	O
321	O

Arsenic	O
species	O
in	O
urine	O
and	O
hair	O

GM	O
(	O
95	O
%	O
CI	O
)	O

p	O
-	O
Value	O

Contaminated	O
Ground	O
Water	O
(	O
n	O
=	O
35	O
)	O

Tap	O
Water	O
(	O
n	O
=	O
10	O
)	O

Child	O

Urine	O
(	O
µg	O
/	O
L	O
)	O

Organic	O
As	O

DMA	O

35	O
.	O
383	O
(	O
27	O
.	O
216	O
–	O
46	O
.	O
000	O
)	O

44	O
.	O
111	O
(	O
28	O
.	O
452	O
–	O
68	O
.	O
388	O
)	O

0	O
.	O
407	O

MMA	O

2	O
.	O
178	O
(	O
1	O
.	O
482	O
–	O
3	O
.	O
199	O
)	O

3	O
.	O
135	O
(	O
2	O
.	O
310	O
–	O
4	O
.	O
255	O
)	O

0	O
.	O
125	O

Subtotal	O

38	O
.	O
249	O
(	O
29	O
.	O
562	O
–	O
49	O
.	O
490	O
)	O

47	O
.	O
792	O
(	O
31	O
.	O
428	O
–	O
72	O
.	O
675	O
)	O

0	O
.	O
392	O

Inorganic	O
As	O

As	O
III	O

0	O
.	O
462	O
(	O
0	O
.	O
276	O
–	O
0	O
.	O
773	O
)	O

0	O
.	O
163	O
(	O
0	O
.	O
064	O
–	O
0	O
.	O
413	O
)	O

0	O
.	O
053	O

As	O
V	O

1	O
.	O
256	O
(	O
1	O
.	O
102	O
–	O
1	O
.	O
432	O
)	O

1	O
.	O
433	O
(	O
1	O
.	O
172	O
–	O
1	O
.	O
752	O
)	O

0	O
.	O
316	O

Subtotal	O

2	O
.	O
091	O
(	O
1	O
.	O
734	O
–	O
2	O
.	O
522	O
)	O

1	O
.	O
845	O
(	O
1	O
.	O
464	O
–	O
2	O
.	O
325	O
)	O

0	O
.	O
494	O

Total	O

40	O
.	O
724	O
(	O
31	O
.	O
750	O
–	O
52	O
.	O
236	O
)	O

49	O
.	O
816	O
(	O
33	O
.	O
049	O
–	O
75	O
.	O
091	O
)	O

0	O
.	O
424	O

Hair	O
(	O
ppm	O
)	O

0	O
.	O
154	O
(	O
0	O
.	O
131	O
–	O
0	O
.	O
180	O
)	O

0	O
.	O
137	O
(	O
0	O
.	O
100	O
–	O
0	O
.	O
187	O
)	O

0	O
.	O
484	O

Arsenic	O
concentrations	O
of	O
the	O
adult	O
and	O
child	O
exposure	O
groups	O
at	O
the	O
first	O
and	O
second	O
tests	O
.	O

Arsenic	O
Species	O
in	O
Urine	O

GM	O
(	O
95	O
%	O
CI	O
)	O

AM	O
±	O
Std	O
(	O
Pre	O
-	O
Post	O
)	O

p	O
-	O
Value	O

1st	O
(	O
Pre	O
)	O

2nd	O
(	O
Post	O
)	O

Adult	O
(	O
n	O
=	O
74	O
)	O

Organic	O
As	O

DMA	O

60	O
.	O
250	O
(	O
50	O
.	O
703	O
–	O
71	O
.	O
596	O
)	O

51	O
.	O
890	O
(	O
43	O
.	O
505	O
–	O
61	O
.	O
892	O
)	O

10	O
.	O
962	O
±	O
68	O
.	O
578	O

0	O
.	O
173	O

MMA	O

3	O
.	O
258	O
(	O
2	O
.	O
292	O
–	O
4	O
.	O
630	O
)	O

2	O
.	O
167	O
(	O
1	O
.	O
459	O
–	O
3	O
.	O
220	O
)	O

1	O
.	O
579	O
±	O
3	O
.	O
703	O

<	O
0	O
.	O
001	O

Subtotal	O

64	O
.	O
638	O
(	O
54	O
.	O
501	O
–	O
76	O
.	O
661	O
)	O

55	O
.	O
532	O
(	O
46	O
.	O
859	O
–	O
65	O
.	O
811	O
)	O

12	O
.	O
541	O
±	O
69	O
.	O
967	O

0	O
.	O
127	O

Inorganic	O
As	O

As	O
III	O

0	O
.	O
130	O
(	O
0	O
.	O
053	O
–	O
0	O
.	O
318	O
)	O

0	O
.	O
006	O
(	O
0	O
.	O
003	O
–	O
0	O
.	O
012	O
)	O

1	O
.	O
269	O
±	O
1	O
.	O
585	O

<	O
0	O
.	O
001	O

As	O
V	O

0	O
.	O
594	O
(	O
0	O
.	O
380	O
–	O
0	O
.	O
927	O
)	O

0	O
.	O
011	O
(	O
0	O
.	O
005	O
–	O
0	O
.	O
023	O
)	O

0	O
.	O
926	O
±	O
0	O
.	O
893	O

<	O
0	O
.	O
001	O

Subtotal	O

1	O
.	O
897	O
(	O
1	O
.	O
389	O
–	O
2	O
.	O
591	O
)	O

0	O
.	O
034	O
(	O
0	O
.	O
015	O
–	O
0	O
.	O
079	O
)	O

2	O
.	O
195	O
±	O
1	O
.	O
897	O

<	O
0	O
.	O
001	O

Total	O

67	O
.	O
348	O
(	O
56	O
.	O
846	O
–	O
79	O
.	O
789	O
)	O

56	O
.	O
356	O
(	O
47	O
.	O
569	O
–	O
66	O
.	O
767	O
)	O

14	O
.	O
736	O
±	O
70	O
.	O
798	O

0	O
.	O
078	O

Child	O
(	O
n	O
=	O
45	O
)	O

Organic	O
As	O

DMA	O

37	O
.	O
160	O
(	O
29	O
.	O
820	O
–	O
46	O
.	O
305	O
)	O

40	O
.	O
781	O
(	O
32	O
.	O
260	O
–	O
51	O
.	O
554	O
)	O

−	O
6	O
.	O
291	O
±	O
44	O
.	O
580	O

0	O
.	O
349	O

MMA	O

1	O
.	O
738	O
(	O
0	O
.	O
928	O
–	O
3	O
.	O
255	O
)	O

1	O
.	O
346	O
(	O
0	O
.	O
715	O
–	O
2	O
.	O
534	O
)	O

0	O
.	O
363	O
±	O
1	O
.	O
927	O

0	O
.	O
212	O

Subtotal	O

40	O
.	O
161	O
(	O
32	O
.	O
361	O
–	O
49	O
.	O
841	O
)	O

43	O
.	O
114	O
(	O
34	O
.	O
098	O
–	O
54	O
.	O
513	O
)	O

−	O
5	O
.	O
928	O
±	O
45	O
.	O
285	O

0	O
.	O
385	O

Inorganic	O
As	O

As	O
III	O

0	O
.	O
037	O
(	O
0	O
.	O
012	O
–	O
0	O
.	O
115	O
)	O

0	O
.	O
002	O
(	O
0	O
.	O
001	O
–	O
0	O
.	O
003	O
)	O

0	O
.	O
765	O
±	O
1	O
.	O
007	O

<	O
0	O
.	O
001	O

As	O
V	O

1	O
.	O
294	O
(	O
1	O
.	O
160	O
–	O
1	O
.	O
442	O
)	O

0	O
.	O
006	O
(	O
0	O
.	O
003	O
–	O
0	O
.	O
015	O
)	O

1	O
.	O
171	O
±	O
0	O
.	O
647	O

<	O
0	O
.	O
001	O

Subtotal	O

1	O
.	O
961	O
(	O
1	O
.	O
664	O
–	O
2	O
.	O
310	O
)	O

0	O
.	O
009	O
(	O
0	O
.	O
003	O
–	O
0	O
.	O
023	O
)	O

1	O
.	O
936	O
±	O
1	O
.	O
210	O

<	O
0	O
.	O
001	O

Total	O

42	O
.	O
482	O
(	O
34	O
.	O
448	O
–	O
52	O
.	O
390	O
)	O

43	O
.	O
446	O
(	O
34	O
.	O
405	O
–	O
54	O
.	O
862	O
)	O

−	O
3	O
.	O
992	O
±	O
45	O
.	O
436	O

0	O
.	O
559	O

Comparison	O
of	O
the	O
diagnostic	O
test	O
results	O
between	O
the	O
adult	O
exposure	O
and	O
control	O
groups	O
.	O

Diagnostic	O
Test	O

AM	O
±	O
Std	O

p	O
-	O
Value	O

Exposure	O
(	O
n	O
=	O
99	O
)	O

Control	O
(	O
n	O
=	O
64	O
)	O

Blood	O
pressure	O

Systolic	O

121	O
.	O
26	O
±	O
15	O
.	O
20	O

132	O
.	O
42	O
±	O
16	O
.	O
47	O

<	O
0	O
.	O
001	O

Diastolic	O

70	O
.	O
61	O
±	O
10	O
.	O
86	O

72	O
.	O
52	O
±	O
9	O
.	O
23	O

0	O
.	O
247	O

Complete	O
blood	O
cell	O
count	O

White	O
blood	O
cell	O

6	O
.	O
32	O
±	O
1	O
.	O
81	O

7	O
.	O
09	O
±	O
2	O
.	O
60	O

0	O
.	O
032	O

Red	O
blood	O
cell	O

4	O
.	O
33	O
±	O
0	O
.	O
44	O

4	O
.	O
69	O
±	O
3	O
.	O
99	O

0	O
.	O
374	O

Hemoglobin	O

13	O
.	O
11	O
±	O
1	O
.	O
66	O

12	O
.	O
61	O
±	O
1	O
.	O
74	O

0	O
.	O
073	O

Platelet	O

250	O
.	O
84	O
±	O
70	O
.	O
56	O

269	O
.	O
77	O
±	O
73	O
.	O
84	O

0	O
.	O
103	O

Liver	O
Function	O
Test	O

Glutamic	O
oxalacetic	O
transaminase	O

26	O
.	O
79	O
±	O
8	O
.	O
33	O

25	O
.	O
27	O
±	O
6	O
.	O
12	O

0	O
.	O
210	O

Glutamic	O
pyruvate	O
transaminase	O

19	O
.	O
91	O
±	O
12	O
.	O
86	O

19	O
.	O
58	O
±	O
9	O
.	O
53	O

0	O
.	O
860	O

Gamma	O
glutamyl	O
transpeptidase	O

31	O
.	O
75	O
±	O
29	O
.	O
40	O

30	O
.	O
67	O
±	O
27	O
.	O
16	O

0	O
.	O
815	O

Renal	O
function	O
test	O

Blood	O
urea	O
nitrogen	O

17	O
.	O
35	O
±	O
5	O
.	O
54	O

18	O
.	O
41	O
±	O
4	O
.	O
51	O

0	O
.	O
205	O

Creatinine	O

0	O
.	O
94	O
±	O
0	O
.	O
20	O

0	O
.	O
89	O
±	O
0	O
.	O
16	O

0	O
.	O
111	O

Beta	O
2	O
microglobulin	O

0	O
.	O
24	O
±	O
0	O
.	O
10	O

0	O
.	O
24	O
±	O
0	O
.	O
09	O

0	O
.	O
969	O

Tumor	B-DS
marker	O

Alpha	B-GP
fetoprotein	I-GP

2	O
.	O
55	O
±	O
1	O
.	O
35	O

2	O
.	O
69	O
±	O
1	O
.	O
49	O

0	O
.	O
521	O

Carcinoembryonic	B-GP
antigen	I-GP

2	O
.	O
79	O
±	O
2	O
.	O
49	O

2	O
.	O
55	O
±	O
1	O
.	O
10	O

0	O
.	O
398	O

Carbohydrate	O
antigen	O
19	O
-	O
9	O

6	O
.	O
79	O
±	O
6	O
.	O
89	O

4	O
.	O
53	O
±	O
3	O
.	O
41	O

0	O
.	O
006	O

Cancer	B-GP
antigen	I-GP
125	I-GP

10	O
.	O
80	O
±	O
4	O
.	O
93	O

10	O
.	O
34	O
±	O
4	O
.	O
30	O

0	O
.	O
601	O

Prostate	B-GP
specific	I-GP
antigen	I-GP

1	O
.	O
68	O
±	O
1	O
.	O
91	O

1	O
.	O
95	O
±	O
2	O
.	O
23	O

0	O
.	O
688	O

cytokeratin	B-GP
-	I-GP
19	I-GP
fragments	O

1	O
.	O
45	O
±	O
0	O
.	O
57	O

1	O
.	O
45	O
±	O
1	O
.	O
03	O

0	O
.	O
956	O

Arsenic	O
concentration	O
in	O
drinking	O
water	O
from	O
the	O
villages	O
.	O

Name	O
of	O
Town	O

Name	O
of	O
Village	O

Source	O

Concentration	O
of	O
As	O
(	O
mg	O
/	O
L	O
)	O

Before	O
the	O
Installation	O
of	O
Filter	O

After	O
The	O
Installation	O
of	O
Filter	O

1st	O

2nd	O

A	O

a	O

ground	O
water	O

0	O
.	O
0253	O

0	O
.	O
0260	O

<	O
0	O
.	O
0015	O

B	O

b	O

ground	O
water	O

0	O
.	O
0232	O

0	O
.	O
0241	O

<	O
0	O
.	O
0015	O

C	O

c	O

ground	O
water	O

0	O
.	O
0176	O

0	O
.	O
0155	O

<	O
0	O
.	O
0015	O

C	O

d	O

Ground	O
water	O
and	O
stream	O
water	O

0	O
.	O
1040	O

0	O
.	O
0972	O

<	O
0	O
.	O
0015	O

C	O

e	O

ground	O
water	O

0	O
.	O
0342	O

0	O
.	O
0286	O

<	O
0	O
.	O
0015	O

Arsenic	O
concentration	O
in	O
the	O
soil	O
and	O
rice	O
crop	O
specimens	O
collected	O
from	O
the	O
studied	O
area	O
.	O

Name	O
of	O
Town	O

Name	O
of	O
Village	O

Average	O
Concentration	O
of	O
As	O
in	O
Soils	O
(	O
mg	O
/	O
kg	O
)	O

Average	O
Concentration	O
of	O
As	O
of	O
Rice	O
(	O
mg	O
/	O
kg	O
)	O

n	O

AM	O
±	O
Std	O

n	O

AM	O
±	O
Std	O

A	O

a	O

28	O

12	O
.	O
531	O
±	O
3	O
.	O
098	O

15	O

0	O
.	O
155	O
±	O
0	O
.	O
082	O

B	O

b	O

12	O

9	O
.	O
472	O
±	O
2	O
.	O
009	O

12	O

0	O
.	O
173	O
±	O
0	O
.	O
091	O

C	O

c	O

20	O

16	O
.	O
367	O
±	O
8	O
.	O
766	O

19	O

0	O
.	O
212	O
±	O
0	O
.	O
169	O

C	O

e	O

30	O

13	O
.	O
835	O
±	O
6	O
.	O
531	O

7	O

0	O
.	O
031	O
±	O
0	O
.	O
026	O

C	O

f	O

14	O

5	O
.	O
274	O
±	O
1	O
.	O
814	O

22	O

0	O
.	O
118	O
±	O
0	O
.	O
042	O

C	O

g	O

10	O

7	O
.	O
142	O
±	O
2	O
.	O
180	O

10	O

0	O
.	O
087	O
±	O
0	O
.	O
040	O

